Biatrial neuroablation attenuates atrial remodeling and vulnerability to atrial fibrillation in canine chronic rapid atrial pacing

Autonomic Neuroscience : Basic & Clinical
Emmanuel MossPierre Pagé

Abstract

We investigated the proposition that an intact cardiac nervous system may contribute to electrophysiological remodeling and increased vulnerability to atrial fibrillation (AF) following chronic rapid atrial pacing (RAP). Baseline study was conducted prior to ablating right and left ganglionated plexuses (RAGP, LAGP) in 11 anesthetized canines (Neuroablation group) and in 11 canines without neuroablation (Intact GP). After being subjected to RAP (400 beats/min) for 6 weeks, animals were reanesthetized for terminal study. The ERP shortening typical of chronic RAP was significantly more pronounced in the Intact GP (baseline: 112 ± 12 to terminal: 80 ± 11 ms) than in the Neuroablation group (113 ± 18 to 102 ± 21 ms, p < .001), and AF inducibility (extrastimulus protocol) showed significantly greater increment in the Intact GP (baseline: 23 ± 19% to terminal: 60 ± 17% of trials) than in the Neuroablation group (18 ± 15% to 27 ± 17%, p = 0.029). Negative chronotropic responses to right vagus nerve stimulation were markedly reduced immediately after the neuroablation procedure but had recovered at terminal study. Vagally-evoked repolarization changes (from 191 unipolar electrograms) occurred in a majority of Intact GP animals in the s...Continue Reading

References

Feb 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·P L PagéR Cardinal
May 1, 1994·The Anatomical Record·B X YuanJ A Armour
Jun 2, 2001·Journal of Cardiovascular Electrophysiology·P SchauerteW M Jackman
Jun 14, 2002·Cardiovascular Research·Maurits AllessieUlrich Schotten
Jul 18, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·UNKNOWN World Medical Association, UNKNOWN American Physiological Society
Mar 11, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Yong-Mei ChaMargaret M Redfield
Feb 10, 2006·Autonomic Neuroscience : Basic & Clinical·Pierre PagéRené Cardinal
May 30, 2006·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Seil OhTodor N Mazgalev
Jul 22, 2008·The American Journal of Cardiology·Demosthenes KatritsisA John Camm
Aug 30, 2008·The American Journal of Cardiology·Stephan DanikVivek Y Reddy
Aug 30, 2008·Circulation Research·Xiao Yan QiStanley Nattel
Dec 17, 2008·Autonomic Neuroscience : Basic & Clinical·René CardinalJ Andrew Armour
Feb 25, 2009·IEEE Transactions on Bio-medical Engineering·Edward J VigmondAlain Vinet
Aug 7, 2009·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Evgeny PokushalovDemosthenes G Katritsis
Sep 11, 2009·The Journal of Thoracic and Cardiovascular Surgery·Shun-ichiro SakamotoRalph J Damiano
Dec 8, 2011·Circulation. Arrhythmia and Electrophysiology·Leonardo CalòErnesto Lioy
Jun 30, 2012·British Journal of Neurosurgery·Chaoyang ChenPrasanna Malaviya
Jan 1, 2014·Pacing and Clinical Electrophysiology : PACE·Shaohua ZhengYinglong Hou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.